BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28667032)

  • 1. Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease.
    Xun C; Zhao Y
    Ann Clin Lab Sci; 2017 May; 47(3):310-314. PubMed ID: 28667032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
    Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
    Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating RBP4 Increase and Its Diagnosis of Chronic Kidney Disease.
    Xun C; Zhao Y; Wang W; Chen C
    Ann Clin Lab Sci; 2018 Mar; 48(2):205-207. PubMed ID: 29678848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.
    Steubl D; Kumar SV; Tato M; Mulay SR; Larsson A; Lind L; Risérus U; Renders L; Heemann U; Carlsson AC; Ärnlöv J; Anders HJ
    Sci Rep; 2017 Feb; 7():43538. PubMed ID: 28240259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
    Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
    Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
    Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
    Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
    J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis.
    Bessa TF; Cordeiro CA; Gonçalves RM; Young LH; Campos WR; Oréfice F; Teixeira AL
    Braz J Infect Dis; 2012; 16(6):540-4. PubMed ID: 23141990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
    Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
    Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
    Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
    PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
    Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
    Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
    Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
    Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
    Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
    Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
    Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
    Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.
    Noto C; Gadelha A; Belangero SI; Spindola LM; Rocha NP; de Miranda AS; Teixeira AL; Cardoso Smith MA; de Jesus Mari J; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Apr; 47(4):467-71. PubMed ID: 23360651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.